← Back to APMD

Apnimed, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 08/09/2026Mar 2026Filed 08/09/2026Jun 2025Filed 08/09/2026Mar 2025Filed 08/09/2026
$12$17
$126$68−$69−$29
324.8

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.